The increased utilization of CT, MR, and PET imaging has prompted the American College of Radiology to revise its Appropriateness Criteria manual. Advances in technology enable the ACR to use a robust search engine for its Web-based version. A PDA-based application is also in the works.
The increased utilization of CT, MR, and PET imaging has prompted the American College of Radiology to revise its Appropriateness Criteria manual. Advances in technology enable the ACR to use a robust search engine for its Web-based version. A PDA-based application is also in the works.
The latest updates to the manual provide a more intuitive format overall. This includes the modality utilization ranking tables at the top of each category and a more consistent terminology. The standard term "CT," for example, replaces alternative references such as CAT scan and computed tomography, said Christine Waldrip, appropriateness criteria program specialist.
"We did not add new topics but updated 55 of the existing ones. These now include some of the more recent technologies," Waldrip said.
A few examples of indications that reflect technology advances are lung cancer staging and workup of solitary pulmonary nodules, uterine cancer, blunt chest trauma and suspected aortic injury, acute trauma of the hand or wrist, and acute pyelonephritis.
Many topics had not been reviewed since 1999. In some cases, only minor editorial modifications were made. But in many others, panel experts had to address the substantive evolution that has affected imaging modalities and their applications.
"CT urography has revolutionized the workup of hematuria, stone disease, and renal cancer staging in many practices. These changes are reflected now in the guidelines," said Dr. Peter L. Choyke, chief of the molecular imaging program at the National Cancer Institute and chair of the Appropriateness Criteria's urology panel.
FDG-PET wasn't even on the list for many illnesses five years ago, and now it is considered a reasonable diagnostic method in many conditions, Choyke said.
A PDA-based version will be launched soon. It's logical, Choyke said, to migrate to handheld devices, which can be updated every day.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.